Adverse Effects of Venetoclax and Ibrutinib Only 1 in 50 Patients had Tumor Lysis Syndrome - 100459

Spotlight
Video

Adverse Effects of Venetoclax and Ibrutinib Only 1 in 50 Patients had Tumor Lysis Syndrome

moasc has 313 videos Subscribe Here

Loading........
Description: Dr. Ann Eapen Division of Hematology/Oncology: UC Irvine discusses Adverse Effects of Venetoclax and Ibrutinib Only 1 in 50 Patients had Tumor Lysis Syndrome at MOASC’s Spotlight On Hematology in Huntington Beach 2018.
Shared By : moasc
Posted on : 02/06/18
Added : 6 months ago



Recommended

Nothing found.